Paul Frankel - Concepedia

Author

Paul Frankel

Also Known As

Cochran, Angela, P Frankel, P H Frankel, P. Frankel, P. Fränkel, P. H. Frankel, Paul Frankel, Paul H Frankel, Paul H. Frankel, Paul Henry Frankel

397

Publications

6.5K

Citations

H-Index

Concepts

All Affiliations

City of Hope City Of Hope National Medical Center University of California, Davis University of Southern California Beckman Research Institute

About

Paul Frankel is an author at City of Hope specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	53	2.1K
2	Health Sciences	9	9	218
3	Engineering	2	2	50
4	Blood Transplantation	2	2	63
5	Biomedical Engineering	1	1	27

Paul Frankel

122

Publications

Citations

H-Index

Page 1

	Year	Citations
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial Nazlı Dizman, Luís Meza, Paulo Gustavo Bergerot, Nature Medicine	2022	427
Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer Suresh S. Ramalingam, Michael L. Maitland, Paul Frankel, Journal of Clinical Oncology Purpose VorinostatAdvanced NsclcFirst-line TherapyOncologyMetronomic Therapy	2009	267
De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer Xiwei Wu, George Somlo, Yang Yu, Journal of Translational Medicine	2012	247
A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study Thehang Luu, Robert J. Morgan, Lucille Leong, Clinical Cancer Research	2008	236
Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma Mark Kirschbaum, Paul Frankel, Leslie Popplewell, Journal of Clinical Oncology	2011	211
Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma Suresh S. Ramalingam, Chandra P. Belani, Christopher Ruel, Journal of Thoracic Oncology OncologyHistone Deacetylase InhibitorMedicinePhase Ii StudyPathology	2009	157
Functional Imaging of Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Using <sup>64</sup>Cu-DOTA-Trastuzumab PET Joanne Mortimer, James R. Bading, David Colcher, Journal of Nuclear Medicine	2013	155
Neural Stem Cell–Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients Jana Portnow, Timothy W. Synold, Behnam Badie, Clinical Cancer Research	2016	155
A phase 1 clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndrome Mark Kirschbaum, Ivana Gojo, Stuart L. Goldberg, British Journal of Haematology	2014	131
Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology George Somlo, Sean K. Lau, Paul Frankel, Breast Cancer Research and Treatment Biomarker (Medicine)Breast OncologyNovel Detection TechnologyMedicineBiomarker Target	2011	126

Page 1